Merit Medical Systems Inc
NASDAQ:MMSI

Watchlist Manager
Merit Medical Systems Inc Logo
Merit Medical Systems Inc
NASDAQ:MMSI
Watchlist
Price: 105.33 USD 0.29% Market Closed
Market Cap: 6.1B USD
Have any thoughts about
Merit Medical Systems Inc?
Write Note

Merit Medical Systems Inc
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merit Medical Systems Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Merit Medical Systems Inc
NASDAQ:MMSI
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Non-Reccuring Items
-$47.7m
CAGR 3-Years
-47%
CAGR 5-Years
6%
CAGR 10-Years
0%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Non-Reccuring Items
-$560m
CAGR 3-Years
-199%
CAGR 5-Years
-44%
CAGR 10-Years
-46%
ICU Medical Inc
NASDAQ:ICUI
Non-Reccuring Items
-$60.8m
CAGR 3-Years
-61%
CAGR 5-Years
14%
CAGR 10-Years
-31%
Align Technology Inc
NASDAQ:ALGN
Non-Reccuring Items
-$44.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Non-Reccuring Items
$6.3m
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
32%
No Stocks Found

Merit Medical Systems Inc
Glance View

Market Cap
6.1B USD
Industry
Health Care

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,446 full-time employees. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.

MMSI Intrinsic Value
87.16 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

Back to Top